eGenesis — Startup Profile
Genome engineering for human-compatible organ transplants
HQ: Delaware, US | Founded: 2015 | Employees: 134 | Stage: Late Stage VC | Website: https://www.egenesis.bio
About
eGenesis is a biotechnology company that operates in genome engineering and transplantation within the healthcare sector. The company's platform focuses on performing multi-gene edits on porcine organs to make them compatible with the human immune system, aiming to alleviate the critical shortage of organs available for transplant. Founded in 2015, the company has raised approximately $454 million in total funding to build out its xenotransplantation platform across multiple organ types including kidney, heart, and liver.
The Take
eGenesis is building a xenotransplantation platform that genetically edits pig organs for human transplantation, targeting the structural shortage of transplantable organs affecting over 100,000 patients on the U.S. waiting list.
Key Metrics
- Latest Valuation: Undisclosed
- Last Round: $100M raised November 2019
- Total Funding: ~$454M
- Headcount: 134
- Founded: 2015
- Est. Runway: 908 months (at $500K/mo burn)
Funding Rounds
- Round: $100M (2019-11-07) — Undisclosed
- Round: Undisclosed (2015-01-01) — Undisclosed
Key People
Key Competitors
- United Therapeutics (Revivicor) —
- Makana Therapeutics —
- Qihan Biotech —
Timeline Highlights
- 2019-11-07: $100M Funding Round
- 2015-01-01: Company Founded
Recent News
- Biotech raises $100 million to test pig-to-human transplants (2019-11-07)
- eGenesis company profile: $454M war chest for human-compatible organs platform (2025-09-18)
Similar Startups
- Solugen — Bio-based chemical manufacturing via a modular enzymatic platform
- Benchling — Unified R&D Cloud for life sciences
- Altos Labs — Cellular rejuvenation programming to reverse disease and transform medicine
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- Insitro — Machine learning-enabled drug discovery and development platform combining high-throughput biology w
More Biotech Startups
- Altos Labs — Cellular rejuvenation programming to reverse disease and transform medicine
- Vilya — Computational biotech platform designing novel molecular structures to target disease biology
- Insitro — Machine learning-enabled drug discovery and development platform combining high-throughput biology w
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- Mammoth Biosciences — CRISPR platform company developing diagnostics and therapeutics
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki